THE INFLUENCE OF KIDNEY BEANS ( PHASEOLUS VULGARIS ) PODS EXTRACT ON OBESITY DEVELOPMENT

A. Yurchenko, N. Raksha, O. Savchuk
Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; Taras Shevchenko National University of Kyiv, Kyiv, Ukraine

Abstract


The influence of kidney beans pods extract on obesity development was investigated. It was found that administration of P. vulgaris pods extract led to decrease of body weight and body mass index of the animals which were on high-calorie diet. Found changes could be result of decrease of food intake by rats treated with extract in compare with rats in high-calorie diet group.

Keywords


obesity, kidney beans pods extract, high-calorie diet

Full Text:

PDF

References


Паньків В. І. Ожиріння як медико-соціальна проблема. Паньків В. І. Практична ангіологія. 2006; 4: 36-42. Українська.

Khan V.N. Pharmacological appraisal of medicinal plants with antidiabetic potential. V.N. Khan, A.K. Najmi, M. Akhtar. J. Pharm. Bioallied. Sci. 2012; 4(1): 27–42. English.

Barrett M.L. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. M.L. Barrett, J.K. Udani. Nutr. J. 2011; 17(24). doi: 10.1186/1475-2891-10-24. English.

Ionescu-Tirgoviste C, Popa E, Mirodon Z,. The effect of a plant mixture on the metabolic equilibrium in patients with type-2 diabetes mellitus. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1989; 41(2):185-192. English.

Рибак В.А. Вплив тривалого застосування густого екстракту квасолі на показники вуглеводного обміну в щурів з метаболічним синдромом на тлі ожиріння. В.А. Рибак, Л.М. Малоштан. Фармакологія та лікарська токсикологія. 2014; 40(4–5): 80 – 84. Українська.

Lissner L., Heitmann B.L. Dietary fat and obesity: evidence from epidemiology. European Journal of Clinical Nutrition. 1995; 49: 79-90. English.

Hubert J.W., Feinleib M., McNamara P.M. Obesity as an independent risk factor for cardiovascular disease: a 26-year followup of participant in the Framingham Heart Study. Circulation. 1983; 67: 968-977. English.


Refbacks

  • There are currently no refbacks.